stockrowAbsci Corporation (ABSI) vs Nurix Therapeutics, Inc. (NRIX)
- Absci Corporation ABSI 10.17 +8.31%
- Nurix Therapeutics, Inc. NRIX 15.30 +3.10%
Absci Corporation and Nurix Therapeutics, Inc. are both Biotechnology companies. Absci Corporation and Nurix Therapeutics, Inc. are of similar size ($1.6B and $1.6B). Absci Corporation has negative trailing earnings, so its P/E is not meaningful; Nurix Therapeutics, Inc. trades at 6.1×. Nurix Therapeutics, Inc. grew revenue faster over the last twelve months: 738.8% against −62.3%. Nurix Therapeutics, Inc. has the higher net margin (42.0% vs −7,756.4%) and the higher return on invested capital (0.00% vs −174.7%). Across the 17 metrics below, Nurix Therapeutics, Inc. leads on 14 and Absci Corporation on 3.
Valuation
Profitability
| Metric | ABSI | NRIX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 68.51% |
| Operating margin | (8,084.50%) | 41.27% | 0.00% |
| Net margin | (7,756.37%) | 42.01% | 0.00% |
| Free cash flow margin | (6,969.83%) | 52.68% | 0.00% |
| Return on equity | (57.72%) | 43.99% | (51.96%) |
| Return on assets | (50.57%) | 34.33% | (46.06%) |
| Return on invested capital | (174.74%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack